http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_379c5fd6f588520091fb73fa353e62f0
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Brandner |
| name | Sebastian Brandner |
| given-name | Sebastian |
| organization-name | Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London Hospitals, NHS Trust, London, England5Department of Neurodegenerative Disease, University College London Institute of Neurology, London, England Division of Neuropathology The National Hospital for Neurology and Neurosurgery University College London NHS Foundation Trust London UK; Department of Neurodegeneration UCL Institute of Neurology London UK Department of Neurosurgery, Friedrich-Alexander University (FAU) of Erlangen-Nürnberg, Erlangen, Germany Medical Research Council Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1, UK. Division of Neuropathology,; MRC Centre for Neuromuscular Diseases, Institute of Neurology, University College London, London WC1N 3BG, UK Division of Neuropathology, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, and Department of Neurodegenerative Disease, Queen Square, Institute of Neurology, University College London Division of Neuropathology and Department of Neurodegenerative Disease Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London, UK; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK Division of Neuropathology Department of Neurodegenerative Disease UCL Queen Square Institute of Neurology Queen Square London WC1N 3BG UK MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and NeurosurgeryQueen Square, London WC1N 3BG, UK 1Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, Queen Square, London, United Kingdom.; 3Division of Neuropathology, the National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, United Kingdom. Epilepsy Center, Department of Neurology University of Erlangen‐Nuremberg Erlangen Germany Division of Neuropathology, Department of Neurodegenerative Disease, University College London Institute of Neurology, Queen Square, London, England Department of Neurodegenerative Disease, University College London (UCL) Institute of Neurology, London WC1N 3BG, United Kingdom; and Department of Neurosurgery, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany Division of Neuropathology, The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust and Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK Department of Neurodegenerative Disease, Institute of Neurology, Queen Square, London WC1N 3BG, UK.; Medical Research Council Prion Unit, Institute of Neurology, Queen Square, London WC1N 3BG, UK.; National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.; Centre for Haematology, Institute of Cell and Molecular Science, Barts and The London, Queen Mary's School of Medicine, 4 Newark Street, London E1 2AT, UK.; Institute of Human Genetics, University of Newcastle upon Tyne, International Centre for Life, Central Parkway, Newcastle upon Tyne, NE1 3BZ, UK. Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology Queen Square, London Division of Neuropathology and Department of Neurodegenerative Disease, Institute of Neurology, London, United Kingdom Department of Neurosurgery, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany Department of Neuropathology UCL Queen Square Institute of Neurology London UK Medical Research Council (MRC) Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK. Department of Neuropathology, National Hospital for Neurology and Neurosurgery, London, UK Division of Neuropathology National Hospital of Neurology and Neurosurgery, UCL Hospitals NHS Foundation Trust London UK From the MRC Centre for Neuromuscular Diseases (Y.-T.L., M.L., A.H., M.M.R., H.H.) and Departments of Molecular Neuroscience (Y.-T.L., J.H., A.H., A.P., D.H., M.M.R., H.H.) and Clinical Neuroscience (C.P.), UCL Institute of Neurology; National Hospital for Neurology and Neurosurgery and UCLH (M.L., J.H., A.H., K.G.S., M.M.R., H.H.), London, UK; Section of Epilepsy (Y.-T.L.), Department of Neurology, Neurological Institute, Taipei Veterans General Hospital; National Yang-Ming University School of... Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, Queen Square, London, UK; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK Authors' Affiliations: 1Division of Neuropathology, Department of Neurodegenerative Disease, University College London (UCL) Institute of Neurology; 2Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London; 3Department of Histopathology, Neural Development Unit, and 4UCL Genomics, UCL Institute of Child Health, Great Ormond Street Hospital, London; and 5Children's Brain Tumour Research Centre, Queen's Medical Centre, Nottingham, United Kingdom Medical Research Council Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, United Kingdom Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK, Division of Neuropathology National Hospital for Neurology and Neurosurgery London; Department of Neurodegenerative Disease University College London Queen Square Institute of Neurology London United Kingdom Department of Neurosurgery, University Hospital Erlangen, Germany; Institut für Molekularbiologie, Abteilung I, University of Zürich, Winterthurerstrasse 190, 8057 Zürich, Switzerland; and Institut für Neuropathologie and Biologisches Zentrallabor University Hospital Zürich, 8091 Zürich, Switzerland Institute of Neuropathology, UniversitätsSpital Zurich, Schmelzbergstrasse 12 CH‐8091 Zurich Switzerland Medical Research Council (MRC) Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College London, London WC1N 3BG, United Kingdom Department of Neurosurgery University Hospital Erlangen Erlangen Germany Medical Research Council Prion Unit and Department of Neurodegenerative Disease, and Division of Neuropathology, Institute of Neurology, University College, Queen Square, London WC1N 3BG, United Kingdom Department of Pathology, National Hospital for Neurology and Neurosurgery, UK Department of Neurosurgery, University Hospital Erlangen, 91054 Erlangen, Germany MRC Prion Unit, Department of Neurodegenerative Disease, Institute of Neurology, University College London, Queen Square, London WC1N 3BG, UK Department of Neurosurgery, Universitätsklinikum Erlangen, and Friedrich-Alexander Universität Erlangen-Nürnberg, Erlangen, Germany Department of Neurodegenerative Disease, UCL Institute of Neurology and Division of Neuropathology, National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK Medical Research Council Prion Unit, Department of Neurodegenerative Disease, University College London Institute of Neurology, London WC1N 3BG, United Kingdom Division of Neuropathology and Department of Neurodegenerative Disease Institute of Neurology Queen Square London From the MRC Centre for Neuromuscular Disease, Neuroimmunology and CSF Laboratory (S.K., O.J.Z., H.M., A.C., M.M.R., M.P.L.), Institute of Neurology, Cancer Division (D.F., J.B., A.C., K.Y., S.D.), Department of Endocrinology (F.C., S.E.B., M.P.L.), and Division of Neuropathology, National Hospital for Neurology and Neurosurgery (Z.J., S.B.), University College London NHS Foundation Trust (S.K.), National Hospital for Neurology and Neurosurgery; Department of Neuromuscular Diseases (S.K., O.J.Z., H... From UCL Institute of Neurology (H.H., S.B., J.C., H.G.P.), London; and Kings College London (P.-W.S.), UK. Department of Neurodegenerative Disease; UCL Queen Square Institute of Neurology; London UK; Division of Neuropathology; The National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust; London UK Department of Neuropathology, University Hospital, CH-8091 Zurich Medical Research Council Prion Unit, Department of Neurodegenerative Diseases, University College London Institute of Neurology, London, England Department of Neurosurgery Universitätsklinikum Erlangen, Friedrich‐Alexander‐Universität Erlangen‐Nürnberg Erlangen Germany Division of Neuropathology, and Department of Neurodegeneration, UCL Institute of Neurology, Queen Square, London, United Kingdom Department of Neurodegenerative Disease, UCL Institute of Neurology, London WC1N 3BG, UK; Division of Neuropathology, The National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London WC1N 3BG, UK From the Stroke Research Group (A.C., D.J.W.), Division of Neuropathology and Department of Neurodegenerative Disease (Z.J., S.B.), and Lysholm Department of Neuroradiology (R.J.), UCL Institute of Neurology, London, UK; The National Hospital for Neurology and Neurosurgery (A.C., R.J., D.J.W.), London, UK; Department of Clinical Neurosciences (J.-C.B.) and Department of Pathology (J.X.), University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Neuropathology (J.-C.B., P.V.),... Department of Neurosurgery, University of Erlangen, Erlangen, Germany Department of Neurosurgery, Medical University Vienna, Vienna, Austria From the Department of Neuromuscular Diseases (A.H., A.C., M.G.H., M.M.R.), UCL Queen Square Institute of Neurology and the National Hospital for Neurology and Neurosurgery, University College London Hospitals; Department of Molecular Neuroscience (A.M.P., H.H.), UCL Queen Square Institute of Neurology; Department of Neuro-ophthalmology (F.B.F.R.C.O.), the National Hospital for Neurology and Neurosurgery, University College London Hospitals; Division of Neuropathology (Z.J., S.B.), the National... Department of Neurosurgery, University of Erlangen-Nuremberg, Erlangen, Germany Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, UK Medical Research Council Prion Unit at University College London, University College London Institute of Prion Diseases , London , United Kingdom; Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology and Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London National Health Service Foundation Trust , London , United Kingdom Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK. Division of Neuropathology, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK. UCL Queen Square Institute of Neurology University College London London UK; Division of Neuropathology, The National Hospital for Neurology and Neurosurgery University College Hospitals NHS Foundation Trust London UK Department of Neurosurgery University of Erlangen‐Nürnberg Erlangen Germany Institute of Neurology, Queen Square, London WC1N 3BG, UK Division of Neuropathology and Department of Neurodegenerative Disease, Institute of Neurology, University College London, London WC1N 3BG, UK MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK MRC Prion Unit and Department of Neurodegenerative Disease, Institute of Neurology, University College, London WC1N 3BG, UK Division of Neuropathology UCL Queen Square Institute of Neurology, and The National Hospital for Neurology and Neurosurgery, University College Hospitals NHS Foundation Trust London UK Institute of Pharmacology and Toxicology, and Biological Central Laboratory, Institute of Laboratory Animal Science, University of Zurich, CH-8057 Zurich, Switzerland; Department of Applied Biosciences, Swiss Federal Institute of Technology, CH-8006 Zurich, Switzerland; University Children Hospital, 4005 Basel, Switzerland; and Institute of Neuropathology, University Hospital, 8091 Zurich, Switzerland Medical Research Council Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, United Kingdom Institute of Neuropathology, University Hospital, CH-8091 Zürich, Switzerland; and Institute of Molecular Biology, Department I, University of Zürich, CH-8093 Zürich, Switzerland Institute of Neuropathology, University Hospital, 8091 Zurich, Switzerland Department of Pathology, Institute of Neuropathology, University of Zürich, CH-8091 Zürich, Switzerland Division of Neuropathology and Department of Neurodegenerative Disease UCL Institute of Neurology London UK MRC Prion Unit Department of Neurodegenerative Disease UCL Institute of Neurology London UK From the Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (Dr Louis); the Department of Pathology, Amsterdam Universities Medical Center/VUmc CCA Brain Tumor Center, Amsterdam, the Netherlands (Dr Wesseling); he Department of Pathology, Princess Máxima Center for Pediatric Oncology, and University Medical Center Utrecht, Utrecht, the Nether Department of Neurosurgery, University Hospital Erlangen , Erlangen 91054 , Germany Medical Research Council Prion Unit and Department of Neurodegenerative Diseases , Institute of Neurology, University College, London WC1N 3BG, United Kingdom Institute of Neurology, University College London, London WC1N 3BG, United Kingdom; MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, The National Hospital for Neurology and NeurosurgeryQueen Square, London WC1N 3BG, UK From the National Hospital for Neurology & Neurosurgery, UCLH NHS Foundation Trust and UCL Institute of Neurology, London, UK. Department of Neurosurgery, University of Erlangen-Nürnberg, Erlangen, Germany. Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK; Division of Neuropathology, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK Department of Neurosurgery, Universitätsklinikum Erlangen, and Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany Medical Research Council (MRC) Prion Unit and Department of Neurodegenerative Disease, University College London Institute of Neurology, Queen Square, London WC1N 3BG, UK. |
Incoming Links
Total number of triples: 379.